1. Home
  2. CRC vs VKTX Comparison

CRC vs VKTX Comparison

Compare CRC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$56.74

Market Cap

4.7B

Sector

Energy

ML Signal

HOLD

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$31.97

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRC
VKTX
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.0B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
CRC
VKTX
Price
$56.74
$31.97
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$72.57
$95.86
AVG Volume (30 Days)
710.0K
1.7M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,669,000,000.00
N/A
Revenue This Year
$12.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.73
N/A
52 Week Low
$43.25
$22.96
52 Week High
$71.98
$43.15

Technical Indicators

Market Signals
Indicator
CRC
VKTX
Relative Strength Index (RSI) 60.98 42.69
Support Level $50.42 $31.58
Resistance Level $63.65 $32.92
Average True Range (ATR) 1.37 1.37
MACD 0.39 -0.05
Stochastic Oscillator 74.16 17.91

Price Performance

Historical Comparison
CRC
VKTX

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: